This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA

Joan Stephenson

JAMA. 1999;281:2175.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Clinicians dealing with the challenge of keeping up with the latest information on anti-HIV drugs and treatment regimens may find some welcome assistance from a set of frequently updated guidelines available on the World Wide Web.

A newly revised version of the Guidelines for the Use of Antiretroviral Agents in HIV Infected Adults and Adolescents—developed by the Panel on Clinical Practices for the Treatment of HIV Infection, a joint effort of the US Department of Health and Human Services and the Henry J. Kaiser Family Foundation—was recently posted to the AIDS Treatment Information Service's Web site (http://www.hivatis.org). A hard copy can be obtained at no charge by calling (800) 448-0440.

The most recent update includes recommendations for the use of the recently approved nucleoside analog reverse transcriptase inhibitor, abacavir.

Another update featuring the panel's recommendations for the use of a recently approved protease inhibitor, amprenavir, . . . [Full Text of this Article]